MicrobeandLab Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • MicrobeandLab's estimated annual revenue is currently $12M per year.(i)
  • MicrobeandLab's estimated revenue per employee is $251,000

Employee Data

  • MicrobeandLab has 48 Employees.(i)
  • MicrobeandLab grew their employee count by 37% last year.

MicrobeandLab's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$60M239N/AN/AN/A
#2
$10M40-17%N/AN/A
#3
$28.9M1154%N/AN/A
#4
$12M4837%N/AN/A
#5
$60M239-2%N/AN/A
#6
$35.6M14226%N/AN/A
#7
$48.2M1925%N/AN/A
#8
$16.3M6525%N/AN/A
#9
$58.5M2334%N/AN/A
#10
$49.9M19952%N/AN/A
Add Company

What Is MicrobeandLab?

Microbe&Lab makes an important contribution to improving people’s health and their quality of life. We combine science-based innovation, diagnostics, technology and healthcare models to provide accessible and easy self-care for everyone. We develop and analyse home use and professional diagnostic tests and services which give insight into personal health and wellbeing.

keywords:N/A

N/A

Total Funding

48

Number of Employees

$12M

Revenue (est)

37%

Employee Growth %

N/A

Valuation

N/A

Accelerator

MicrobeandLab News

2022-04-19 - Fluid flow stimulates chemosynthesis in a Greek salad of ...

Making the microbe rate measurements and identifying the various microbes at the hydrothermal vent site was a collaborative effort. That...

2022-04-19 - How engineered microbes could cut aviation emissions

A startup using genetically engineered microbes, light, and carbon dioxide in an attempt to make an alternative to petroleum-based products...

2022-04-13 - Engineered microbe protects the gut microbiome from antibiotics

Researchers have now engineered microbes to produce an enzyme that degrades ?-lactam antibiotics in the guts of mice without affecting the...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$6.7M48167%N/A
#2
$7.7M484700%N/A
#3
$10.4M4814%N/A
#4
$4.8M4871%$34M
#5
$5.6M48-19%N/A